+++
# â”€â”€â”€ğŸ—‚ï¸ åŸºç¡€ä¿¡æ¯â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
type        = "posts"
date        = 2026-02-11T23:13:09+08:00
lastmod     = 2026-02-11T23:13:09+08:00
slug        = ""
title       = "åŒ»è¯ç›‘ç®¡å‘¨åˆŠ - 2026-02-11"
# â”€â”€â”€âš™ï¸ æ¸²æŸ“æ§åˆ¶â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
toc         = true
math        = false
mermaid     = false
gallery     = false
weight      = 0
# â”€â”€â”€ğŸ› ï¸ å¢å¼ºè®¾ç½®â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
draft          = false
aliases        = []
expiryDate     = ""
paid           = false
license        = ""
featuredImage  = ""
# â”€â”€â”€ğŸ“ˆ æ–‡ç« å±æ€§â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
description    = "åŒ»è¯ç›‘ç®¡å‘¨åˆŠæ—¥æŠ¥ï¼Œæ¶µç›–æ–°è¯é€Ÿé€’, ç›‘ç®¡åŠ¨æ€, æ³•è§„æŒ‡å—ç­‰å†…å®¹ã€‚"
keywords       = ["åŒ»è¯", "ç›‘ç®¡", "æ–°é—»"]
author         = [""]
series         = [""]
categories     = ["pharma"]
tags           = ["EMA", "FDA"]
+++

## æ–°è¯é€Ÿé€’

FDA 2026-02-06 [FDA Approves Vybrique (sildenafil) Oral Film to Treat Men with Erectile Dysfunction](https://www.drugs.com/newdrugs/fda-approves-vybrique-sildenafil-oral-film-men-erectile-dysfunction-6722.html)

FDA 2026-02-05 [Novo Nordisk Introduces Ozempic Pill; Available in the US Q2 2026](https://www.drugs.com/newdrugs/novo-nordisk-introduces-ozempic-pill-available-us-q2-2026-6720.html)

FDA 2026-02-08 [Genentechâ€™s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)](https://www.drugs.com/clinical_trials/genentech-s-fenebrutinib-first-investigational-medicine-over-decade-reduces-disability-progression-22299.html)

FDA 2026-02-05 [Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program](https://www.drugs.com/clinical_trials/cumberland-pharmaceuticals-receives-fda-fast-track-designation-ifetroban-duchenne-muscular-22297.html)

## ç›‘ç®¡åŠ¨æ€

FDA 2026-02-11 [F.H. Investments Inc dba Asteria Health. Birmingham, AL. 483 issued 12/19/2025](http://www.fda.gov/about-fda/fda-commissioner/fh-investments-inc-dba-asteria-health-birmingham-al-483-issued-12192025)

FDA 2026-02-06 [Ipca Laboratories Limited - 12/5/2025](http://www.fda.gov/drugs/cder-foia-electronic-reading-room/ipca-laboratories-limited-1252025)

EMA 2026-02-09 [Concept paper on the revision of the guidelines on Good Manufacturing Practice for medicinal products - Annex 15 - Qualification and validation](https://www.ema.europa.eu/en/documents/scientific-guideline/concept-paper-revision-guidelines-good-manufacturing-practice-medicinal-products-annex-15-qualification-validation_en.pdf)

## ç§‘å­¦æŒ‡å— (å…¶ä»–)

EMA 2026-02-10 [Validation checklist for Type II quality variations](https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/validation-checklist-type-ii-quality-variations_en.docx)

EMA 2026-02-05 [Procedural advice for veterinary vaccine antigen master  file (VAMF) certification](https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/procedural-advice-veterinary-vaccine-antigen-master-file-vamf-certification_en.pdf)

